Source: International Congress 2018 – ILDs: From bench to bedside
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Mansouri (Boston, United States of America), G. Willis (Boston, United States of America), A. Fernandez-Gonzalez (Boston, United States of America), M. Reis (Boston, United States of America), S. Mitsialis (Boston, United States of America), S. Kourembanas (Boston, United States of America). Late Breaking Abstract - Mesenchymal stromal cell exosomes prevent and revert experimental pulmonary fibrosis through systemic modulation of monocyte phenotypes. 261

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Caveolin-1 derived peptide LTI-03 promotes epithelial cell survival and attenuates pulmonary fibrosis Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia Year: 2019 Late Breaking Abstract - Myeloid-derived microvesicles as acute mediators of sepsis-induced lung vascular inflammation Source: Virtual Congress 2020 – Cellular involvement in lung injury Year: 2020 Late Breaking Abstract - WNT/ß-catenin signaling induces cellular senescence in lung alveolar epithelial cells Source: International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease Year: 2019 Mesenchymal stem cells and conditioned medium in myofibroblast modulation and collagen production in vascular adventitia and parenchyma of experimental pulmonary fibrosis model Source: International Congress 2016 – ILD pathogenesis Year: 2016 Late Breaking Abstract - High cumulative dose of allogeneic mesenchymal stem cells in patients with progressive idiopathic pulmonary fibrosis Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia Year: 2019 Induced pluripotent stem cells conditioned media (iPS-cm) modulates macrophage phenotype in the fibrotic lung Source: International Congress 2014 – Lung cell biology in injury and repair Year: 2014 Mesenchymal stem cells from adipose tissue reduce bleomycin-induced lung remodeling in late stage Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Late Breaking Abstract - Mesenchymal stromal cells as a salvage treatment for persistent ARDS Source: Virtual Congress 2020 – New insights into mechanical ventilation in the intensive care unit Year: 2020 LSC - 2021 - Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension Year: 2021 The secretome of induced pluripotent stem cells (iPSC) modulates macrophage phenotype in the fibrotic lung Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Late Breaking Abstract - Loss of PTEN induces alveolar epithelial cell senescence resulting in lung fibrosis via activated NF-?B Source: International Congress 2018 – ILDs: From bench to bedside Year: 2018 PP206 – Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids Source: ERS Lung Science Conference 2021 Year: 2021 Mesenchymal stromal cells and macrophages in sepsis: new insights Source: Eur Respir J, 51 (4) 1800510; 10.1183/13993003.00510-2018 Year: 2018 Late Breaking Abstract - A comprehensive analysis of endothelial cell markers in pulmonary fibrosis Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension Year: 2021 Pluripotent stem cells isolated from adult human lung tissue exhibit anti-fibrotic properties Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung Year: 2013 Late Breaking Abstract - Novel mesenchymal pathways that initiate emphysema Source: International Congress 2018 – Intercellular communication in tissue remodelling Year: 2018 Pulmonary alveolar proteinosis: iPS derived macrophages as in-vitro disease model and potential source for novel gene and cell therapies Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 Regulation and role of notch signaling in epithelial progenitor cell differentiation and proliferation in the normal and the fibrotic lung Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis Year: 2013 Mesenchymal stem cells reduce hypoxia-induced apoptosis in alveolar epithelial cells by modulating hypoxic signaling Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease Year: 2015 Mast cells and fibroblasts work in concert to aggravate pulmonary fibrosis: Role of transmembrane SCF and PAR-2/PKCalpha/Raf-1/p44/42 signaling pathway Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013